ArticleInfectious Disease Modelling2026
Rapid assessment of local disease control measures against the Marburg virus outbreak in Ethiopia in late 2025.
Article in Infectious Disease Modelling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In November 2025, Marburg virus caused the first outbreak of Marburg virus disease (MVD) in Ethiopia. By December 15, a total of 14 laboratory-confirmed cases were reported, including 9 deaths, corresponding to a case fatality ratio of 64.3% among confirmed cases. In the absence of licenced vaccines or antivirals, non-pharmaceutical interventions (NPIs) were implemented to control transmission. We developed a stochastic epidemic model incorporating a stochastic exponential growth process with reporting adjustment to assess the effectiveness of NPIs. The reporting ratio was modelled using a beta distribution, and transmission parameters were estimated via Markov chain Monte Carlo with particle filtering for likelihood calculation. Using pre-NPI data (November 12-23), we estimated an exponential growth rate of 0.012 (95% credible interval [CrI]: 0.008, 0.014) per day, corresponding to an initial reproduction number of 1.13 (95% CrI: 1.09, 1.16). We projected 64 cases (95% CrI: 19, 189) and 41 deaths (95% CrI: 12, 122) during post-NPI period (November 24 to December 15) without interventions. Compared with 4 observed cases, NPIs were associated with an estimated effectiveness of 93.7% (95% CrI: 78.9, 97.9). These findings indicated moderate transmissibility of MVD, and a potential transmission risk reduction following the implementation of control measures, underscoring the importance of timely intervention and sustained surveillance regarding local MVD activities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.